Ultrasound is helpful to differentiate Bethesda class III thyroid nodules

Tan, 1997, Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging, Ann Intern Med, 126, 226, 10.7326/0003-4819-126-3-199702010-00009

Guth, 2009, Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination, Eur J Clin Invest, 39, 699, 10.1111/j.1365-2362.2009.02162.x

Hegedüs, 2004, Clinical practice. The thyroid nodule, N Engl J Med, 351, 1764, 10.1056/NEJMcp031436

Mandel, 2004, A 64-year-old woman with a thyroid nodule, JAMA, 292, 2632, 10.1001/jama.292.21.2632

Md, 2016, 2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer, Thyroid, 26, 1, 10.1089/thy.2015.0020

Cibas, 2009, NCI Thyroid FNA State of the Science Conference. The Bethesda system for reporting thyroid cytopathology, Am J Clin Pathol, 132, 658, 10.1309/AJCPPHLWMI3JV4LA

Alexander, 2002, Assessment of nondiagnostic ultrasound-guided fine needle aspirations of thyroid nodules, J Clin Endocrinol Metab, 87, 4924, 10.1210/jc.2002-020865

Melo, 2014, TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas, J Clin Endocrinol Metab, 99, E754, 10.1210/jc.2013-3734

Kim, 2011, Role of sonographic diagnosis in managing Bethesda class III nodules, AJNR Am J Neuroradiol, 32, 2136, 10.3174/ajnr.A2686

Carr, 2013, Radiologic and clinical predictors of malignancy in the follicular lesion of undetermined significance of the thyroid, Endocr Pathol, 24, 62, 10.1007/s12022-013-9240-4

Yoo, 2015, Repeat diagnoses of Bethesda category III thyroid nodules: what to do next?, PLoS One, 10, e0130138, 10.1371/journal.pone.0130138

Park, 2015, Malignancy risk and characteristics of thyroid nodules with two consecutive results of atypia of undetermined significance or follicular lesion of undetermined significance on cytology, Eur Radiol, 25, 2601, 10.1007/s00330-015-3668-5

Gweon, 2013, Thyroid nodules with Bethesda system III cytology: can ultrasonography guide the next step?, Ann Surg Oncol, 20, 3083, 10.1245/s10434-013-2990-x

Ryu, 2014, Atypia of undetermined significance on thyroid fine needle aspiration: surgical outcome and risk factors for malignancy., Ann Surg Treat Res, 86, 109, 10.4174/astr.2014.86.3.109

Kim, 2016, Triage of patients with AUS/FLUS on thyroid cytopathology: effectiveness of the multimodal diagnostic techniques, Cancer Med, 5, 769, 10.1002/cam4.636

Kamaya, 2015, Atypia of undetermined significance and follicular lesions of undetermined significance: sonographic assessment for prediction of the final diagnosis, J Ultrasound Med, 34, 767, 10.7863/ultra.34.5.767

Kuru, 2016, Risk factors associated with malignancy and with triage to surgery in thyroid nodules classified as Bethesda category III (AUS/FLUS), Eur J Surg Oncol, 42, 87, 10.1016/j.ejso.2015.09.026

Lee, 2014, Atypia of undetermined significance in thyroid fine-needle aspiration cytology: prediction of malignancy by US and comparison of methods for further management, Ann Surg Oncol, 21, 2326, 10.1245/s10434-014-3568-y

Moon, 2015, Malignancy risk stratification in thyroid nodules with nondiagnostic results at cytologic examination: combination of thyroid imaging reporting and data system and the Bethesda System, Radiology, 274, 287, 10.1148/radiol.14140359

Rosario, 2014, Thyroid nodules with atypia or follicular lesions of undetermined significance (Bethesda Category III): importance of ultrasonography and cytological subcategory, Thyroid, 24, 1115, 10.1089/thy.2013.0650

Yoon, 2014, A nomogram for predicting malignancy in thyroid nodules diagnosed as atypia of undetermined significance/follicular lesions of undetermined significance on fine needle aspiration, Surgery, 155, 1006, 10.1016/j.surg.2013.12.035

Yoon, 2016, Subcategorization of atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS): a study applying Thyroid Imaging Reporting and Data System (TIRADS), Clin Endocrinol (Oxf, 85, 275, 10.1111/cen.12987

Knobloch, 2011, Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias, J Craniomaxillofac Surg, 39, 91, 10.1016/j.jcms.2010.11.001

Whiting, 2011, QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies, Ann Intern Med, 155, 529, 10.7326/0003-4819-155-8-201110180-00009

Papini, 2002, Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features, J Clin Endocrinol Metab, 87, 1941, 10.1210/jcem.87.5.8504

Shimura, 2005, Distinct diagnostic criteria for ultrasonographic examination of papillary thyroid carcinoma: a multicenter study, Thyroid, 15, 251, 10.1089/thy.2005.15.251

Moon, 2008, Benign and malignant thyroid nodules: US differentiation—multicenter retrospective study, Radiology, 247, 762, 10.1148/radiol.2473070944

Pang, 2010, Correlation between indeterminate aspiration cytology and final histopathology of thyroid neoplasms, Surgery, 148, 532, 10.1016/j.surg.2010.01.018

Yoon, 2010, How to approach thyroid nodules with indeterminate cytology, Ann Surg Oncol, 17, 2147, 10.1245/s10434-010-0992-5

Layfield, 2008, Post-thyroid FNA testing and treatment options: a synopsis of the National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference, Diagn Cytopathol, 36, 442, 10.1002/dc.20832

Lee, 2009, Comparison of cytological results obtained by repeated US-guided fine-needle aspiration biopsies of thyroid nodules: focus on the rate of malignancy and diagnostic concordance, Diagn Cytopathol, 37, 492, 10.1002/dc.21043

Ferris, 2015, American Thyroid Association statement on surgical application of molecular profiling for thyroid nodules: current impact on perioperative decision making, Thyroid, 25, 760, 10.1089/thy.2014.0502